INTERCEPT PHARMACEUTICALS IN (ICPT)
US45845P1084 - Common Stock
| TTM (2023-9-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -61.61M | 221.82M | -91.43M | -274.88M | -344.68M | |||
| Depreciation Amortization | 377.00K | 592.00K | 2.81M | 3.12M | 3.66M | |||
| Change In Working Capital | -25.31M | 21.92M | -19.69M | 2.00M | 19.33M | |||
| Interest Paid | N/A | N/A | N/A | N/A | N/A | |||
| Taxes Paid | N/A | 5.05M | N/A | N/A | N/A | |||
| Other non cash items | 23.52M | -271.11M | 67.23M | 99.74M | 85.07M | |||
| OPERATING CASH FLOW | -63.02M | -26.78M | -41.07M | -170.03M | -236.61M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 186.00K | -568.00K | -397.00K | -3.89M | -1.14M | |||
| Other Investing Activity | 160.92M | 262.42M | 71.12M | 166.71M | -187.85M | |||
| INVESTING CASH FLOW | 161.11M | 261.85M | 70.73M | 162.82M | -188.99M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | -268.41M | 78.61M | 0.00 | 223.42M | |||
| Stock Issued/Repurchased | 1.32M | 1.68M | -75.81M | 1.30M | 236.25M | |||
| Other Financing Activity | -428.00K | -592.00K | -1.68M | -1.99M | -2.16M | |||
| FINANCING CASH FLOW | -115.97M | -267.32M | 1.12M | -690.00K | 457.52M | |||
| Exchange Rate Effect | 1.36M | -6.30M | -2.02M | -1.22M | -390.00K | |||
| CHANGE IN CASH | -16.52M | -38.55M | 28.75M | -9.12M | 31.53M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -63.02M | -26.78M | -41.07M | -170.03M | -236.61M | |||
| Capital Expenditure | 186.00K | -568.00K | -397.00K | -3.89M | -1.14M | |||
| FREE CASH FLOW | -62.83M | -27.35M | -41.46M | -173.92M | -237.75M | |||
All data in USD